109 related articles for article (PubMed ID: 15686917)
1. 5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds.
Lewis TA; Bayless L; DiPesa AJ; Eckman JB; Gillard M; Libertine L; Scannell RT; Wypij DM; Young MA
Bioorg Med Chem Lett; 2005 Feb; 15(4):1083-5. PubMed ID: 15686917
[TBL] [Abstract][Full Text] [Related]
2. Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity.
Lewis TA; Young MA; Arrington MP; Bayless L; Cai X; Collart P; Eckman JB; Ellis JL; Ene DG; Libertine L; Nicolas JM; Scannell RT; Wels BF; Wenberg K; Wypij DM
Bioorg Med Chem Lett; 2004 Nov; 14(22):5591-4. PubMed ID: 15482930
[TBL] [Abstract][Full Text] [Related]
3. 5-lipoxygenase inhibitors with histamine H(1) receptor antagonist activity.
Lewis TA; Bayless L; Eckman JB; Ellis JL; Grewal G; Libertine L; Marie Nicolas J; Scannell RT; Wels BF; Wenberg K; Wypij DM
Bioorg Med Chem Lett; 2004 May; 14(9):2265-8. PubMed ID: 15081022
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 5-lipoxygenase: development of hydroxamic acids and hydroxyureas as potential therapeutic agents.
Salmon JA; Jackson WP; Garland LG
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():109-12. PubMed ID: 1847758
[No Abstract] [Full Text] [Related]
5. Novel dual acting molecules possessing 5-lipoxygenase enzyme inhibition and histamine H(1) receptor antagonist properties.
Scannell RT; Arrington MP; Bayless L; Cai X; Eckman JB; Eckert M; Ene DG; Ellis JL; Hussoin S; Latham GM; Lewis TA; Libertine L; Nicolas J; Selig WM; Schwartz CE; Wels BF; Wypij DM; Young MA; Zou D
Inflamm Res; 2004 Mar; 53 Suppl 1():S33-4. PubMed ID: 15054606
[No Abstract] [Full Text] [Related]
6. Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity.
Hamer RR; Tegeler JJ; Kurtz ES; Allen RC; Bailey SC; Elliott ME; Hellyer L; Helsley GC; Przekop P; Freed BS; White J; Martin LL
J Med Chem; 1996 Jan; 39(1):246-52. PubMed ID: 8568814
[TBL] [Abstract][Full Text] [Related]
7. [Pyrrolo(2,3-c)quinolines and pyrrolo(3,4-d)quinolines--synthesis and investigation of lipoxygenase inhibition].
Görlitzer K; Fabian J; Frohberg P; Drutkowski G
Pharmazie; 2002 Apr; 57(4):243-9. PubMed ID: 11998442
[TBL] [Abstract][Full Text] [Related]
8. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms.
Roumestan C; Henriquet C; Gougat C; Michel A; Bichon F; Portet K; Jaffuel D; Mathieu M
Clin Exp Allergy; 2008 Jun; 38(6):947-56. PubMed ID: 18498541
[TBL] [Abstract][Full Text] [Related]
9. The effect of a novel, dual function histamine H1 receptor antagonist/5-lipoxygenase enzyme inhibitor on in vivo dermal inflammation and extravasation.
Giannaras A; Selig W; Ellis J; Hullinger T
Eur J Pharmacol; 2005 Jan; 506(3):265-71. PubMed ID: 15627437
[TBL] [Abstract][Full Text] [Related]
10. Wy-45,911: a novel leukotriene antagonist with lipoxygenase inhibitory activity.
Musser JH; Kubrak DM; Chang J; Lewis AJ
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():536-9. PubMed ID: 2959109
[No Abstract] [Full Text] [Related]
11. Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase.
Araico A; Terencio MC; Alcaraz MJ; Domínguez JN; León C; Ferrándiz ML
Life Sci; 2006 May; 78(25):2911-8. PubMed ID: 16360707
[TBL] [Abstract][Full Text] [Related]
12. Structure and activity relationships leading to the discovery of ICI D2138, a selective, potent and orally active inhibitor of 5-lipoxygenase.
Crawley GC; Bird TG; Bruneau P; Dowell RI; Edwards PN; Foster SJ; Girodeau JM; McMillan RM; Walker ER; Waterson D
J Lipid Mediat; 1993; 6(1-3):249-57. PubMed ID: 8395247
[TBL] [Abstract][Full Text] [Related]
13. Antipsoriatic anthrones with modulated redox properties. 4. Synthesis and biological activity of novel 9,10-dihydro-1,8-dihydroxy-9-oxo-2-anthracenecarboxylic and -hydroxamic acids.
Müller K; Prinz H
J Med Chem; 1997 Aug; 40(17):2780-7. PubMed ID: 9276024
[TBL] [Abstract][Full Text] [Related]
14. Screening of some rare endemic Italian plants for inhibitory activity on 5-lipoxygenase.
Prieto JM; Bader A; Martini F; Ríos JL; Morelli I
Fitoterapia; 2005 Dec; 76(7-8):725-7. PubMed ID: 16242264
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitors.
Stewart AO; Bhatia PA; Martin JG; Summers JB; Rodriques KE; Martin MB; Holms JH; Moore JL; Craig RA; Kolasa T; Ratajczyk JD; Mazdiyasni H; Kerdesky FA; DeNinno SL; Maki RG; Bouska JB; Young PR; Lanni C; Bell RL; Carter GW; Brooks CD
J Med Chem; 1997 Jun; 40(13):1955-68. PubMed ID: 9207936
[TBL] [Abstract][Full Text] [Related]
16. Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis.
Vidal C; Gómez-Hernández A; Sánchez-Galán E; González A; Ortega L; Gómez-Gerique JA; Tuñón J; Egido J
J Pharmacol Exp Ther; 2007 Jan; 320(1):108-16. PubMed ID: 17015640
[TBL] [Abstract][Full Text] [Related]
17. 5-lipoxygenase-activating protein inhibitors: development of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103).
Hutchinson JH; Li Y; Arruda JM; Baccei C; Bain G; Chapman C; Correa L; Darlington J; King CD; Lee C; Lorrain D; Prodanovich P; Rong H; Santini A; Stock N; Prasit P; Evans JF
J Med Chem; 2009 Oct; 52(19):5803-15. PubMed ID: 19739647
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of celecoxib analogues possessing a N-difluoromethyl-1,2-dihydropyrid-2-one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
J Med Chem; 2009 Mar; 52(6):1525-9. PubMed ID: 19296694
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of a series of hydroxamic acid derivatives on 5-lipoxygenase and cyclooxygenase from neutrophils and 12-lipoxygenase from platelets and their in vivo effects on inflammation and anaphylaxis.
Huang FC; Shoupe TS; Lin CJ; Lee TD; Chan WK; Tan J; Schnapper M; Suh JT; Gordon RJ; Sonnino PA
J Med Chem; 1989 Aug; 32(8):1836-42. PubMed ID: 2502629
[TBL] [Abstract][Full Text] [Related]
20. Discovery of hydroxamic acid analogs as dual inhibitors of phosphodiesterase-1 and -5.
Dan A; Shiyama T; Yamazaki K; Kusunose N; Fujita K; Sato H; Matsui K; Kitano M
Bioorg Med Chem Lett; 2005 Sep; 15(18):4085-90. PubMed ID: 16005625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
